Veeva Systems (VEEV) Stock Forecast & Price Target

Compare

4,635 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

VEEV Analyst Ratings

Moderate Buy

16 Buy

6 Hold

0 Sell

Based on 22 analysts giving stock ratings to

Veeva

Systems

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

VEEV Stock 12 Month Forecast

Average Price Target

$316.81

▲(38.05% Upside)

Based on 22 Wall Street analysts offering 12 month price targets for Veeva Systems in the last 3 months. The average price target is $316.81 with a high forecast of $380.00 and a low forecast of $222.00. The average price target represents a 38.05% change from the last price of $229.49.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"209":"$209","252":"$252","295":"$295","338":"$338","381":"$381"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":380,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$380.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":316.81,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$316.81</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":222,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$222.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[209,252,295,338,381],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Mar<br/>2025","6":"Jun<br/>2025","9":"Sep<br/>2025","12":"Dec<br/>2025","25":"Dec<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,240.41,251.1476923076923,261.8853846153846,272.62307692307695,283.3607692307692,294.09846153846155,304.8361538461538,315.57384615384615,326.3115384615385,337.0492307692308,347.7869230769231,358.5246153846154,369.2623076923077,{"y":380,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,240.41,246.28692307692307,252.16384615384615,258.04076923076923,263.9176923076923,269.7946153846154,275.6715384615385,281.54846153846154,287.4253846153846,293.3023076923077,299.1792307692308,305.05615384615385,310.9330769230769,{"y":316.81,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,240.41,238.99384615384616,237.5776923076923,236.16153846153847,234.7453846153846,233.32923076923078,231.91307692307691,230.49692307692308,229.08076923076922,227.6646153846154,226.24846153846153,224.8323076923077,223.41615384615386,{"y":222,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":227.46,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 50,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 5</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":210.25,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 51,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 7</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":233.26,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 33,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 6</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":224.14,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 28,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":227.9,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":232.07,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 39,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 18, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":278.63,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":282.9,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 29,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":281.35,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 33,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":269.98,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 35,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":293.26,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 41,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":291.2,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 38,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":240.41,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 32,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$380.00

Average Price Target$316.81

Lowest Price Target$222.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Scott Schoenhaus

KeyBanc

―

Hold

―

Downgraded

12/12/25

Analysts Offer Insights on Healthcare Companies: Veeva Systems (NYSE: VEEV) and Humana (NYSE: HUM)

Craig Hettenbach

Morgan Stanley

$222

Buy

-3.26%

Downside

Initiated

12/05/25

Veeva Systems Faces Competitive Threats from Salesforce: Analyst Issues Sell RatingWe think Salesforce could win Sanofi (#10 pharma company) and are also watching for decisions at JNJ (#1), AstraZeneca (#6), Lilly (#10) and Amgen (#13).

Tyler Radke

Citi

$349→$319

Buy

39.00%

Upside

Reiterated

11/24/25

Veeva price target lowered to $319 from $349 at CitiVeeva price target lowered to $319 from $349 at Citi

Stan Berenshteyn

Wells Fargo

$341→$333

Buy

45.10%

Upside

Reiterated

11/24/25

Veeva Systems: Buy Rating Affirmed Amid Growth Potential and Strategic Advancements

Jailendra Singh

Truist Financial

$275

Hold

19.83%

Upside

Reiterated

11/24/25

Analysts Have Conflicting Sentiments on These Healthcare Companies: Edgewise Therapeutics (NASDAQ: EWTX), Veeva Systems (NYSE: VEEV) and Cormedix (NASDAQ: CRMD)

Karl Keirstead

UBS

$310→$280

Hold

22.01%

Upside

Reiterated

11/21/25

Veeva price target lowered to $280 from $310 at UBSVeeva price target lowered to $280 from $310 at UBS

Saket Kalia

Barclays

$325→$305

Buy

32.90%

Upside

Reiterated

11/21/25

Barclays Reaffirms Their Buy Rating on Veeva Systems (VEEV)

Joseph Vruwink

Robert W. Baird

$314→$319

Buy

39.00%

Upside

Reiterated

11/21/25

Veeva price target raised to $319 from $314 at BairdVeeva price target raised to $319 from $314 at Baird

Kenneth Wong

Oppenheimer

$325

Buy

41.62%

Upside

Reiterated

11/21/25

Oppenheimer Reaffirms Their Buy Rating on Veeva Systems (VEEV)

Kirk Materne

Evercore ISI

$295

Hold

28.55%

Upside

Reiterated

11/21/25

Evercore ISI Sticks to Their Hold Rating for Veeva Systems (VEEV)

Dylan Becker

William Blair

―

Buy

―

Reiterated

11/21/25

Veeva Systems: Strong Position and Future Potential Justify Buy Rating Despite CRM Concerns

Hannah Rudoff

Piper Sandler

$355

Buy

54.69%

Upside

Reiterated

11/21/25

Piper Sandler Sticks to Their Buy Rating for Veeva Systems (VEEV)

Ryan MacDonald

Needham

$355

Buy

54.69%

Upside

Reiterated

11/21/25

Veeva Systems: Strong Market Position and Growth Opportunities Justify Buy Rating

David Hynes

Canaccord Genuity

$300→$280

Hold

22.01%

Upside

Reiterated

11/21/25

Veeva price target lowered to $280 from $300 at CanaccordVeeva price target lowered to $280 from $300 at Canaccord

Sean Dodge

BMO Capital

$300

Hold

30.72%

Upside

Reiterated

11/21/25

BMO Capital Keeps Their Hold Rating on Veeva Systems (VEEV)

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Scott Schoenhaus

KeyBanc

―

Hold

―

Downgraded

12/12/25

Analysts Offer Insights on Healthcare Companies: Veeva Systems (NYSE: VEEV) and Humana (NYSE: HUM)

Craig Hettenbach

Morgan Stanley

$222

Buy

-3.26%

Downside

Initiated

12/05/25

Tyler Radke

Citi

$349→$319

Buy

39.00%

Upside

Reiterated

11/24/25

Veeva price target lowered to $319 from $349 at CitiVeeva price target lowered to $319 from $349 at Citi

Stan Berenshteyn

Wells Fargo

$341→$333

Buy

45.10%

Upside

Reiterated

11/24/25

Veeva Systems: Buy Rating Affirmed Amid Growth Potential and Strategic Advancements

Jailendra Singh

Truist Financial

$275

Hold

19.83%

Upside

Reiterated

11/24/25

Analysts Have Conflicting Sentiments on These Healthcare Companies: Edgewise Therapeutics (NASDAQ: EWTX), Veeva Systems (NYSE: VEEV) and Cormedix (NASDAQ: CRMD)

Karl Keirstead

UBS

$310→$280

Hold

22.01%

Upside

Reiterated

11/21/25

Veeva price target lowered to $280 from $310 at UBSVeeva price target lowered to $280 from $310 at UBS

Saket Kalia

Barclays

$325→$305

Buy

32.90%

Upside

Reiterated

11/21/25

Barclays Reaffirms Their Buy Rating on Veeva Systems (VEEV)

Joseph Vruwink

Robert W. Baird

$314→$319

Buy

39.00%

Upside

Reiterated

11/21/25

Veeva price target raised to $319 from $314 at BairdVeeva price target raised to $319 from $314 at Baird

Kenneth Wong

Oppenheimer

$325

Buy

41.62%

Upside

Reiterated

11/21/25

Oppenheimer Reaffirms Their Buy Rating on Veeva Systems (VEEV)

Kirk Materne

Evercore ISI

$295

Hold

28.55%

Upside

Reiterated

11/21/25

Evercore ISI Sticks to Their Hold Rating for Veeva Systems (VEEV)

Dylan Becker

William Blair

―

Buy

―

Reiterated

11/21/25

Veeva Systems: Strong Position and Future Potential Justify Buy Rating Despite CRM Concerns

Hannah Rudoff

Piper Sandler

$355

Buy

54.69%

Upside

Reiterated

11/21/25

Piper Sandler Sticks to Their Buy Rating for Veeva Systems (VEEV)

Ryan MacDonald

Needham

$355

Buy

54.69%

Upside

Reiterated

11/21/25

Veeva Systems: Strong Market Position and Growth Opportunities Justify Buy Rating

David Hynes

Canaccord Genuity

$300→$280

Hold

22.01%

Upside

Reiterated

11/21/25

Veeva price target lowered to $280 from $300 at CanaccordVeeva price target lowered to $280 from $300 at Canaccord

Sean Dodge

BMO Capital

$300

Hold

30.72%

Upside

Reiterated

11/21/25

BMO Capital Keeps Their Hold Rating on Veeva Systems (VEEV)

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Veeva Systems

1 Month

xxx

Success Rate

17/26 ratings generated profit

Average Return

+1.22%

reiterated a xxx

rating 21 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 65.38% of your transactions generating a profit, with an average return of +1.22% per trade.

3 Months

xxx

Success Rate

12/19 ratings generated profit

Average Return

+3.15%

reiterated a xxx

rating 18 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 63.16% of your transactions generating a profit, with an average return of +3.15% per trade.

1 Year

Rishi JaluriaRBC Capital

Success Rate

18/25 ratings generated profit

Average Return

+11.31%

reiterated a buy rating 22 days ago

Copying Rishi Jaluria's trades and holding each position for 1 Year would result in 72.00% of your transactions generating a profit, with an average return of +11.31% per trade.

2 Years

xxx

Success Rate

20/26 ratings generated profit

Average Return

+16.65%

reiterated a xxx

rating 21 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 76.92% of your transactions generating a profit, with an average return of +16.65% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

VEEV Analyst Recommendation Trends

Rating

Aug 25

Sep 25

Oct 25

Nov 25

Dec 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, VEEV has received 32 Buy Ratings, 12 Hold Ratings, and 2 Sell Ratings. VEEV average Analyst price target in the past 3 months is 316.81.

Each month's total comprises the sum of three months' worth of ratings.

VEEV Financial Forecast

VEEV Earnings Forecast

Next quarter’s earnings estimate for VEEV is $1.93 with a range of $1.91 to $2.04. The previous quarter’s EPS was $2.04. VEEV beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.07% of the time in the same period. In the last calendar year VEEV has Performed in-line its overall industry.

VEEV Sales Forecast

Next quarter’s sales forecast for VEEV is $810.65M with a range of $807.60M to $822.06M. The previous quarter’s sales results were $811.24M. VEEV beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.62% of the time in the same period. In the last calendar year VEEV has Performed in-line its overall industry.

VEEV Stock Forecast FAQ

What is VEEV’s average 12-month price target, according to analysts?

Based on analyst ratings, Veeva Systems’s 12-month average price target is 316.81.

What is VEEV’s upside potential, based on the analysts’ average price target?

Veeva Systems has 38.05% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is VEEV a Buy, Sell or Hold?

Veeva Systems has a consensus rating of Moderate Buy which is based on 16 buy ratings, 6 hold ratings and 0 sell ratings.

What is Veeva Systems’s price target?

The average price target for Veeva Systems is 316.81. This is based on 22 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $380.00 ,the lowest forecast is $222.00. The average price target represents 38.05% Increase from the current price of $229.49.

What do analysts say about Veeva Systems?

Veeva Systems’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 22 Wall Streets Analysts.

How can I buy shares of VEEV?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Veeva Systems (VEEV) Stock Forecast & Price Target

VEEV Analyst Ratings

VEEV Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Veeva Systems

VEEV Analyst Recommendation Trends

VEEV Financial Forecast

VEEV Earnings Forecast

VEEV Sales Forecast

VEEV Stock Forecast FAQ

Detailed List of Analyst Forecasts